ProShare Advisors’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $911K | Sell |
6,625
-526
| -7% | -$72.3K | ﹤0.01% | 858 |
|
|
2025
Q1 | $1.29M | Sell |
7,151
-1,697
| -19% | -$306K | ﹤0.01% | 750 |
|
|
2024
Q4 | $1.39M | Buy |
8,848
+1,967
| +29% | +$308K | ﹤0.01% | 792 |
|
|
2024
Q3 | $1.25M | Buy |
6,881
+1,727
| +34% | +$314K | ﹤0.01% | 753 |
|
|
2024
Q2 | $946K | Sell |
5,154
-711
| -12% | -$131K | ﹤0.01% | 761 |
|
|
2024
Q1 | $1.04M | Buy |
5,865
+486
| +9% | +$86.5K | ﹤0.01% | 777 |
|
|
2023
Q4 | $667K | Buy |
5,379
+740
| +16% | +$91.8K | ﹤0.01% | 884 |
|
|
2023
Q3 | $538K | Buy |
4,639
+158
| +4% | +$18.3K | ﹤0.01% | 889 |
|
|
2023
Q2 | $526K | Buy |
4,481
+185
| +4% | +$21.7K | ﹤0.01% | 924 |
|
|
2023
Q1 | $344K | Sell |
4,296
-577
| -12% | -$46.2K | ﹤0.01% | 1126 |
|
|
2022
Q4 | $386K | Buy |
4,873
+362
| +8% | +$28.7K | ﹤0.01% | 1092 |
|
|
2022
Q3 | $315K | Buy |
4,511
+161
| +4% | +$11.2K | ﹤0.01% | 1124 |
|
|
2022
Q2 | $285K | Sell |
4,350
-2,028
| -32% | -$133K | ﹤0.01% | 1240 |
|
|
2022
Q1 | $424K | Sell |
6,378
-668
| -9% | -$44.4K | ﹤0.01% | 1392 |
|
|
2021
Q4 | $493K | Buy |
7,046
+5
| +0.1% | +$350 | ﹤0.01% | 1453 |
|
|
2021
Q3 | $368K | Sell |
7,041
-1,600
| -19% | -$83.6K | ﹤0.01% | 1392 |
|
|
2021
Q2 | $588K | Buy |
8,641
+1,581
| +22% | +$108K | ﹤0.01% | 1418 |
|
|
2021
Q1 | $544K | Buy |
7,060
+1,022
| +17% | +$78.7K | ﹤0.01% | 1383 |
|
|
2020
Q4 | $362K | Buy |
+6,038
| New | +$362K | ﹤0.01% | 1485 |
|